ICD-10 · PDGM grouping
G21 Secondary parkinsonism
All 8 codes in the G21 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
8
Can lead a claim
7
Cannot lead a claim
1
What CMS assigns to G21
7 of the 8 codes group to Neuro Rehabilitation; 1 is assigned no clinical group. 7 of the 8 count toward the Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease comorbidity subgroup; 1 is assigned none. 7 of the 8 can lead a claim. CMS attaches a code-first note to 1 of the 8.
- Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease: can award the low comorbidity tier as a secondary diagnosis.
Code first
CMS grouper convention 8, on G21.2. Code first:
- , if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
Every code in G21
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| G21.0 | Malignant neuroleptic syndrome | Can lead a claim | B | None |
| G21.1 Other drug-induced secondary parkinsonism | ||||
| G21.11 | Neuroleptic induced parkinsonism | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.19 | Other drug induced secondary parkinsonism | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.2 | Secondary parkinsonism due to other external agents | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.3 | Postencephalitic parkinsonism | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.4 | Vascular parkinsonism | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.8 | Other secondary parkinsonism | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
| G21.9 | Secondary parkinsonism, unspecified | Can lead a claim | B | Spinal Muscular Atrophy, Systemic atrophy and Motor Neuron Disease |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue